Evidence map›Paper›PMID 20110260›Full record

ArticleNucleic acids research2010

Binding of aminoglycoside antibiotics to helix 69 of 23S rRNA.

Ann E Scheunemann, William D Graham, Franck A P Vendeix, Paul F Agris

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Overproduction of gentamicin B in industrial strainMetabolic engineering communications · 2019
    Article
  7. Mutations in GeneAntimicrobial agents and chemotherapy · 2018
    Article
  8. Review
  9. Article
  10. Small Molecule-Based Pattern Recognition To Classify RNA Structure.Journal of the American Chemical Society · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Therapeutics based on stop codon readthrough.Annual review of genomics and human genetics · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ann E ScheunemannDepartment of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27695-7622, USA.
William D Graham
Franck A P Vendeix
Paul F Agris
North Carolina State University · US

Funding

TRANSFER RNA STRUCTURE DURING PROTEIN SYNTHESISR01GM023037 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI AGRIS, PAUL F · 1985 to 2010
$1.3M
NIGMS NIH HHS GM23037
6 · The paper itself

Abstract

Aminoglycosides antibiotics negate dissociation and recycling of the bacterial ribosome's subunits by binding to Helix 69 (H69) of 23S rRNA. The differential binding of various aminoglycosides to the chemically synthesized terminal domains of the Escherichia coli and human H69 has been characterized using spectroscopy, calorimetry and NMR. The unmodified E. coli H69 hairpin exhibited a significantly higher affinity for neomycin B and tobramycin than for paromomycin (K(d)s = 0.3 +/- 0.1, 0.2 +/- 0.2 and 5.4 +/- 1.1 microM, respectively). The binding of streptomycin was too weak to assess. In contrast to the E. coli H69, the human 28S rRNA H69 had a considerable decrease in affinity for the antibiotics, an important validation of the bacterial target. The three conserved pseudouridine modifications (Psi1911, Psi1915, Psi1917) occurring in the loop of the E. coli H69 affected the dissociation constant, but not the stoichiometry for the binding of paromomycin (K(d) = 2.6 +/- 0.1 microM). G1906 and G1921, observed by NMR spectrometry, figured predominantly in the aminoglycoside binding to H69. The higher affinity of the E. coli H69 for neomycin B and tobramycin, as compared to paromomycin and streptomycin, indicates differences in the efficacy of the aminoglycosides.

Indexed as

AminoglycosidesAnti-Bacterial AgentsBinding SitesCalorimetryCircular DichroismEscherichia coliFramycetinHumansNuclear Magnetic Resonance, BiomolecularNucleic Acid ConformationRNA, Ribosomal, 23SAminoglycosidesAnti-Bacterial AgentsFramycetinRNA, Ribosomal, 23S

Identifiers

PMID20110260
PMCPMC2875026
OpenAlexW2098548967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.